{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:48:17Z","timestamp":1792601297976,"version":"4.5.0"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K08HL141623"],"award-info":[{"award-number":["K08HL141623"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research","doi-asserted-by":"publisher","award":["F30HL162459"],"award-info":[{"award-number":["F30HL162459"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH2010727"],"award-info":[{"award-number":["W81XWH2010727"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K08HL141623"],"award-info":[{"award-number":["K08HL141623"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"Division of Intramural Research","doi-asserted-by":"publisher","award":["F30HL162459"],"award-info":[{"award-number":["F30HL162459"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH2010727"],"award-info":[{"award-number":["W81XWH2010727"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disorder without curative therapies, underscoring the critical unmet need for identification of novel therapeutic strategies. eNAMPT (extracellular nicotinamide phosphoribosyltransferase) is a damage-associated molecular pattern protein (DAMP) and TLR4 (Toll-like receptor 4) ligand that contributes to the severity of radiation-induced lung fibrosis and nonalcoholic steatohepatitis\u2013associated hepatic fibrosis. This study investigates eNAMPT as a druggable target in human and preclinical IPF using the eNAMPT-neutralizing ALT-100 monoclonal antibody (mAb). Blood, peripheral blood mononuclear cells (PBMCs), and lung tissues from patients with IPF and from an experimental bleomycin-induced lung fibrosis model in C57Bl6 mice were analyzed. Biochemical and histologic measurements, as well as gene expression through bulk and single-cell RNA sequencing of human PBMCs and murine lung tissues, were performed. Human studies revealed NAMPT expression to be significantly increased in plasma, lung tissues, and PBMCs from subjects with IPF, correlating with disease severity and inversely associated with IPF survival. Bleomycin-exposed mice exhibited increased inflammatory indices associated with lung fibrosis development (including NAMPT levels), as well as physiologic lung stiffening and TGF-\u03b2 pathway\u2013related protein and gene expression, with each index significantly mitigated in mice receiving ALT-100 mAb. Single-cell RNA sequencing studies demonstrated the ALT-100 mAb to reverse the bleomycin-induced dramatic expansion of alveolar type 2 epithelium and induction of endothelial cell\u2013 and epithelial cell\u2013to\u2013mesenchymal\/myofibroblast transitions. These finding support the fundamental involvement of eNAMPT\/TLR4 signaling pathway in lung fibrosis pathobiology, with eNAMPT neutralization a viable therapeutic strategy to directly address the unmet need for novel IPF treatments.<\/jats:p>","DOI":"10.1165\/rcmb.2024-0342oc","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T11:19:21Z","timestamp":1742815161000},"page":"572-585","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":15,"title":["eNAMPT Is a Novel DAMP and Therapeutic Target in Human and Murine Pulmonary Fibrosis"],"prefix":"10.1093","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6363-2414","authenticated-orcid":false,"given":"Nancy G.","family":"Casanova","sequence":"first","affiliation":[{"name":"Center for Inflammation Science and Systems Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose D.","family":"Herazo-Maya","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of South Florida School of Medicine, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie L.","family":"Kempf","sequence":"additional","affiliation":[{"name":"Center for Inflammation Science and Systems Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda L.","family":"Sun","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Pediatrics, Medicine, and Cellular and Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin H.","family":"Song","sequence":"additional","affiliation":[{"name":"Center for Inflammation Science and Systems Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Center for Inflammation Science and Systems Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Canizales Galaviz","sequence":"additional","affiliation":[{"name":"Center for Inflammation Science and Systems Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Sun","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Pediatrics, Medicine, and Cellular and Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Camp","sequence":"additional","affiliation":[{"name":"Center for Inflammation Science and Systems Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie G.","family":"Ledford","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Pediatrics, Medicine, and Cellular and Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley D.","family":"Hellinger","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Pediatrics, Medicine, and Cellular and Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisela","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Center for Inflammation Science and Systems Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Y.","family":"Zhao","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0965-3326","authenticated-orcid":false,"given":"Avraham","family":"Unterman","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Rosas","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Baylor University, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Duncan","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Alabama Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J.","family":"Thannikal","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Tulane University, New Orleans, Louisiana; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew K.","family":"Hufford","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Pediatrics, Medicine, and Cellular and Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Pediatrics, Medicine, and Cellular and Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"Zaghloul","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Pediatrics, Medicine, and Cellular and Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Gupta","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Pediatrics, Medicine, and Cellular and Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bime","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Pediatrics, Medicine, and Cellular and Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Sammani","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Pediatrics, Medicine, and Cellular and Molecular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben N.","family":"Stansfield","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona Health Sciences, Tucson, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona Health Sciences, Tucson, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annadurai","family":"Anandhan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona Health Sciences, Tucson, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Disney","sequence":"additional","affiliation":[{"name":"Center for RNA Medicine and Department of Chemistry, The Herbert Wertheim University of Florida Scripps Research Institute, Jupiter, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikseng","family":"Ooi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona Health Sciences, Tucson, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaira L.","family":"Kee","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Florida, Gainesville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Karampitsakos","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of South Florida School of Medicine, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3172-3132","authenticated-orcid":false,"given":"Panayiotis V.","family":"Benos","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Florida, Gainesville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5917-4601","authenticated-orcid":false,"given":"Naftali","family":"Kaminski","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Inflammation Science and Systems Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe G. N.","family":"Garcia","sequence":"additional","affiliation":[{"name":"Center for Inflammation Science and Systems Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"2026012204143265900_bib1","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00296-021-05002-2","article-title":"Lung fibrosis in autoimmune diseases and hypersensitivity: how to separate these from idiopathic pulmonary fibrosis","volume":"42","author":"Popper","year":"2022","journal-title":"Rheumatol Int"},{"key":"2026012204143265900_bib2","doi-asserted-by":"crossref","first-page":"102287","DOI":"10.1016\/j.pupt.2024.102287","article-title":"The tolerability and efficacy of antifibrotic therapy in patients with idiopathic pulmonary fibrosis: results from a real-world study","volume":"84","author":"Zhao","year":"2024","journal-title":"Pulm Pharmacol Ther"},{"key":"2026012204143265900_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/cells11010143","article-title":"Differential discontinuation profiles between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis","volume":"11","author":"Takehara","year":"2022","journal-title":"Cells"},{"key":"2026012204143265900_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fmed.2018.00043","article-title":"The role of immune and inflammatory cells in idiopathic pulmonary fibrosis","volume":"5","author":"Desai","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"2026012204143265900_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1165\/rcmb.2013-0366TR","article-title":"Danger-associated molecular patterns and danger signals in idiopathic pulmonary fibrosis","volume":"51","author":"Ellson","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012204143265900_bib6","doi-asserted-by":"crossref","first-page":"205ra136","DOI":"10.1126\/scitranslmed.3005964","article-title":"Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis","volume":"5","author":"Herazo-Maya","year":"2013","journal-title":"Sci Transl Med"},{"key":"2026012204143265900_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S2213-2600(17)30349-1","article-title":"Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study","volume":"5","author":"Herazo-Maya","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2026012204143265900_bib8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.201607-1525OC","article-title":"Microbes are associated with host innate immune response in idiopathic pulmonary fibrosis","volume":"196","author":"Huang","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204143265900_bib9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1165\/rcmb.2007-0330OC","article-title":"The role of high mobility group box1 in pulmonary fibrosis","volume":"39","author":"Hamada","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012204143265900_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1465-9921-10-126","article-title":"Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study","volume":"10","author":"He","year":"2009","journal-title":"Respir Res"},{"key":"2026012204143265900_bib11","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm.4192","article-title":"Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice","volume":"22","author":"Liang","year":"2016","journal-title":"Nat Med"},{"key":"2026012204143265900_bib12","doi-asserted-by":"crossref","first-page":"13135","DOI":"10.1038\/srep13135","article-title":"Unique Toll-like receptor 4 activation by NAMPT\/PBEF induces NFkappaB signaling and inflammatory lung injury","volume":"5","author":"Camp","year":"2015","journal-title":"Sci Rep"},{"key":"2026012204143265900_bib13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1165\/rcmb.2021-0357OC","article-title":"eNAMPT is a novel damage-associated molecular pattern protein that contributes to the severity of radiation-induced lung fibrosis","volume":"66","author":"Garcia","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012204143265900_bib14","doi-asserted-by":"crossref","first-page":"916159","DOI":"10.3389\/fphys.2022.916159","article-title":"eNAMPT neutralization preserves lung fluid balance and reduces acute renal injury in porcine sepsis\/VILI-induced inflammatory lung injury","volume":"13","author":"Sammani","year":"2022","journal-title":"Front Physiol"},{"key":"2026012204143265900_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trsl.2007.02.007","article-title":"Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations","volume":"150","author":"Gao","year":"2007","journal-title":"Transl Res"},{"key":"2026012204143265900_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1165\/rcmb.2012-0519OC","article-title":"Nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory lung injury","volume":"51","author":"Moreno-Vinasco","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012204143265900_bib17","doi-asserted-by":"crossref","first-page":"2002536","DOI":"10.1183\/13993003.02536-2020","article-title":"Endothelial eNAMPT amplifies pre-clinical acute lung injury: efficacy of an eNAMPT-neutralising monoclonal antibody","volume":"57","author":"Quijada","year":"2021","journal-title":"Eur Respir J"},{"key":"2026012204143265900_bib18","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/01.CCM.0000260243.22758.4F","article-title":"Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome","volume":"35","author":"Bajwa","year":"2007","journal-title":"Crit Care Med"},{"key":"2026012204143265900_bib19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41598-021-04444-9","article-title":"eNAMPT neutralization reduces preclinical ARDS severity via rectified NFkB and Akt\/mTORC2 signaling","volume":"12","author":"Bermudez","year":"2022","journal-title":"Sci Rep"},{"key":"2026012204143265900_bib20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s13054-019-2697-x","article-title":"Development of a biomarker mortality risk model in acute respiratory distress syndrome","volume":"23","author":"Bime","year":"2019","journal-title":"Crit Care"},{"key":"2026012204143265900_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.trsl.2020.12.008","article-title":"Strategies to DAMPen COVID-19-mediated lung and systemic inflammation and vascular injury","volume":"232","author":"Bime","year":"2021","journal-title":"Transl Res"},{"key":"2026012204143265900_bib22","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1164\/rccm.200712-1822OC","article-title":"Essential role of pre-B-cell colony enhancing factor in ventilator-induced lung injury","volume":"178","author":"Hong","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204143265900_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1164\/rccm.200404-563OC","article-title":"Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury","volume":"171","author":"Ye","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204143265900_bib24","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/CIRCULATIONAHA.116.024557","article-title":"Nicotinamide phosphoribosyltransferase promotes pulmonary vascular remodeling and is a therapeutic target in pulmonary arterial hypertension","volume":"135","author":"Chen","year":"2017","journal-title":"Circulation"},{"key":"2026012204143265900_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1165\/rcmb.2019-0164OC","article-title":"Direct extracellular NAMPT involvement in pulmonary hypertension and vascular remodeling. transcriptional regulation by SOX and HIF-2alpha","volume":"63","author":"Sun","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012204143265900_bib26","doi-asserted-by":"crossref","first-page":"100181","DOI":"10.1016\/j.jtauto.2022.100181","article-title":"eNAMPT\/TLR4 inflammatory cascade activation is a key contributor to SLE Lung vasculitis and alveolar hemorrhage","volume":"6","author":"Tumurkhuu","year":"2023","journal-title":"J Transl Autoimmun"},{"key":"2026012204143265900_bib27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00109-020-01892-0","article-title":"Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis","volume":"98","author":"Colombo","year":"2020","journal-title":"J Mol Med (Berl)"},{"key":"2026012204143265900_bib28","doi-asserted-by":"crossref","first-page":"H415","DOI":"10.1152\/ajpheart.00468.2012","article-title":"Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling","volume":"304","author":"Pillai","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026012204143265900_bib29","doi-asserted-by":"crossref","first-page":"103059","DOI":"10.1016\/j.ebiom.2020.103059","article-title":"Role of secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in prostate cancer progression: novel biomarker and therapeutic target","volume":"61","author":"Sun","year":"2020","journal-title":"EBioMedicine"},{"key":"2026012204143265900_bib30","doi-asserted-by":"crossref","first-page":"e007010","DOI":"10.1136\/jitc-2023-007010","article-title":"Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer","volume":"11","author":"Travelli","year":"2023","journal-title":"J Immunother Cancer"},{"key":"2026012204143265900_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.trsl.2021.06.002","article-title":"Involvement of eNAMPT\/TLR4 signaling in murine radiation pneumonitis: protection by eNAMPT neutralization","volume":"239","author":"Garcia","year":"2022","journal-title":"Transl Res"},{"key":"2026012204143265900_bib32","doi-asserted-by":"crossref","first-page":"e22825","DOI":"10.1096\/fj.202201972RR","article-title":"Involvement of eNAMPT\/TLR4 inflammatory signaling in progression of non-alcoholic fatty liver disease, steatohepatitis, and fibrosis","volume":"37","author":"Sun","year":"2023","journal-title":"FASEB J"},{"key":"2026012204143265900_bib33","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204143265900_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1165\/rcmb.2017-0155OC","article-title":"Novel mechanism for nicotinamide phosphoribosyltransferase inhibition of TNF-alpha-mediated apoptosis in human lung endothelial cells","volume":"59","author":"Oita","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012204143265900_bib35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12871-022-01718-1","article-title":"Circulating eNAMPT as a biomarker in the critically ill: acute pancreatitis, sepsis, trauma, and acute respiratory distress syndrome","volume":"22","author":"Bime","year":"2022","journal-title":"BMC Anesthesiol"},{"key":"2026012204143265900_bib36","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1096\/fj.11-183970","article-title":"Role of sphingolipids in murine radiation-induced lung injury: protection by sphingosine 1-phosphate analogs","volume":"25","author":"Mathew","year":"2011","journal-title":"FASEB J"},{"key":"2026012204143265900_bib37","article-title":"Peripheral blood single-cell sequencing uncovers common and specific immune aberrations in fibrotic lung diseases [preprint]","author":"Zhao","year":"2023"},{"key":"2026012204143265900_bib38","doi-asserted-by":"crossref","first-page":"eaba1983","DOI":"10.1126\/sciadv.aba1983","article-title":"Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis","volume":"6","author":"Adams","year":"2020","journal-title":"Sci Adv"},{"key":"2026012204143265900_bib39","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/s41467-020-15647-5","article-title":"Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis","volume":"11","author":"Tsukui","year":"2020","journal-title":"Nat Commun"},{"key":"2026012204143265900_bib40","doi-asserted-by":"crossref","first-page":"900022","DOI":"10.3389\/fimmu.2022.900022","article-title":"Small peptide derivatives within the carbohydrate recognition domain of SP-A2 modulate asthma outcomes in mouse models and human cells","volume":"13","author":"Francisco","year":"2022","journal-title":"Front Immunol"},{"key":"2026012204143265900_bib41","doi-asserted-by":"crossref","first-page":"18579","DOI":"10.1038\/s41598-021-98161-y","article-title":"Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis","volume":"11","author":"Suzuki","year":"2021","journal-title":"Sci Rep"},{"key":"2026012204143265900_bib42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1164\/rccm.202306-0979OC","article-title":"Single-cell profiling reveals immune aberrations in progressive idiopathic pulmonary fibrosis","volume":"210","author":"Unterman","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204143265900_bib43","doi-asserted-by":"crossref","first-page":"20458940211059712","DOI":"10.1177\/20458940211059712","article-title":"Endothelial eNAMPT drives EndMT and preclinical PH: rescue by an eNAMPT-neutralizing mAb","volume":"11","author":"Ahmed","year":"2021","journal-title":"Pulm Circ"},{"key":"2026012204143265900_bib44","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1172\/JCI12568","article-title":"Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis","volume":"107","author":"Kolb","year":"2001","journal-title":"J Clin Invest"},{"key":"2026012204143265900_bib45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.matbio.2017.12.009","article-title":"Thrombospondin-1 regulation of latent TGF-beta activation: a therapeutic target for fibrotic disease","volume":"68-69","author":"Murphy-Ullrich","year":"2018","journal-title":"Matrix Biol"},{"key":"2026012204143265900_bib46","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N Engl J Med"},{"key":"2026012204143265900_bib47","article-title":"Galecto announces topline results from phase 2b GALACTIC-1 trial of GB0139 for the treatment of idiopathic pulmonary fibrosis [press release]","author":"Galecto Inc","year":"2023"},{"key":"2026012204143265900_bib48","first-page":"486","article-title":"Trials and treatments: an update on pharmacotherapy for idiopathic pulmonary fibrosis","volume":"13","author":"Thong","year":"2023","journal-title":"Life (Basel)"},{"key":"2026012204143265900_bib49","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Raghu","year":"2012","journal-title":"N Engl J Med"},{"key":"2026012204143265900_bib50","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3390\/ph14121322","article-title":"A Humanized monoclonal antibody targeting extracellular nicotinamide phosphoribosyltransferase prevents aggressive prostate cancer progression","volume":"14","author":"Sun","year":"2021","journal-title":"Pharmaceuticals"},{"key":"2026012204143265900_bib51","doi-asserted-by":"crossref","first-page":"116103","DOI":"10.1016\/j.biopha.2023.116103","article-title":"An eNAMPT-neutralizing mAb reduces post-infarct myocardial fibrosis and left ventricular dysfunction","volume":"170","author":"Liu","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"2026012204143265900_bib52","doi-asserted-by":"crossref","first-page":"e1052180","DOI":"10.1080\/23723556.2015.1052180","article-title":"New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology","volume":"3","author":"Roulston","year":"2016","journal-title":"Mol Cell Oncol"},{"key":"2026012204143265900_bib53","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00280-009-1125-3","article-title":"Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data","volume":"65","author":"von Heideman","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"2026012204143265900_bib54","first-page":"e20240918","article-title":"Safety, tolerability and pharmacokinetics of the eNAMPT-neutralizing ALT-100 mAb in healthy volunteers","volume":"3","author":"Miele","year":"2024","journal-title":"J Clin Res Clin Trials"},{"key":"2026012204143265900_bib55","doi-asserted-by":"crossref","first-page":"e98850","DOI":"10.1172\/jci.insight.98850","article-title":"TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung","volume":"3","author":"Bhattacharyya","year":"2018","journal-title":"JCI Insight"},{"key":"2026012204143265900_bib56","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00109-021-02113-y","article-title":"The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis","volume":"99","author":"Bolourani","year":"2021","journal-title":"J Mol Med (Berl)"},{"key":"2026012204143265900_bib57","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","article-title":"Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis","volume":"199","author":"Reyfman","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204143265900_bib58","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1513\/pats.200601-012TK","article-title":"Matrix metalloproteases in aberrant fibrotic tissue remodeling","volume":"3","author":"Pardo","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"2026012204143265900_bib59","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1194\/jlr.M026039","article-title":"Inhibition of serine palmitoyltransferase delays the onset of radiation-induced pulmonary fibrosis through the negative regulation of sphingosine kinase-1 expression","volume":"53","author":"Gorshkova","year":"2012","journal-title":"J Lipid Res"},{"key":"2026012204143265900_bib60","doi-asserted-by":"crossref","first-page":"17534666231181262","DOI":"10.1177\/17534666231181262","article-title":"Linkage of NAMPT promoter variants to eNAMPT secretion, plasma eNAMPT levels, and ARDS severity","volume":"17","author":"Lynn","year":"2023","journal-title":"Ther Adv Respir Dis"},{"key":"2026012204143265900_bib61","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1165\/rcmb.2014-0117OC","article-title":"The NAMPT promoter is regulated by mechanical stress, signal transducer and activator of transcription 5, and acute respiratory distress syndrome-associated genetic variants","volume":"51","author":"Sun","year":"2014","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/73\/4\/572\/66195240\/ajrcmb_73_4_572.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/73\/4\/572\/66195240\/ajrcmb_73_4_572.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:17:22Z","timestamp":1769073442000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/73\/4\/572\/8404973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,10,1]]},"published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2024-0342oc","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"2024-07-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}